Regulatory And Cost Implications For Switching Injectable Delivery Formats

Source: Thermo Fisher Scientific

Since there are various options for injectable formats, it’s not an uncommon practice to launch a large molecule in one format and then later decide to switch the delivery format. This common practice often transpires as a lifecycle management strategy that not only provides cost-effective solutions and supply chain continuity, but also provides patient benefits.

In this webinar, hear industry expert, Christy Eatmon, discuss:

  • Evaluating regulatory and cost implications
  • Trends for switching
  • Release profile options
  • Supply chain requirements and lead times
access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma